| (210) | Number of the EPO application | 17758388 |
| (220) | Filing date of the EPO application | 2017.08.17 |
| (80) | EPO patent specification publication (B) | EPB nr. 27/2019, 2019.07.03 |
| (110) | EPO patent number | 3347352 |
| (21) | Number of the application | e 2018 0701 |
| (71) | Name(s) of applicant(s), code of the country | Gilead Sciences, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | GRAUPE Michael, US;
HENRY Steven J., US;
LINK John O., US;
ROWE Charles William, US;
SAITO Roland D., US;
SCHROEDER Scott D., US;
STEFANIDIS Dimitrios, US;
TSE Winston C., US;
ZHANG Jennifer R., US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD Sciences Inc., US; |
| (54) | Title of the invention | THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/14 (2006.01.01); A61P 31/18 (2006.01.01); A61K 31/4439 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.08.31 |
| (30) | Priority | 201662377312 P, 2016.08.19, US; 201762457555 P, 2017.02.10, US |
| (86) | International application | PCT/US2017/047416, 2017.08.17 |
| (87) | International publication | WO 2018/035359, 2018.02.22 |